Similar Posts
1942–1969: Dr. Lauretta Bender, child psychiatrist from Hell
Child psychiatrist, Dr. Lauretta Bender, began her experimental electroshock “treatments” in children in 1942 at Bellevue Hospital. She experimented extensively on helpless children whom she “diagnosed” with “autistic schizophrenia.” Some of the children were as young as 3 years of age. She used multiple electroshock (ECT) “treatments” at Bellevue Hospital…
FDA warns diet drugs contain Prozac and Librium
Pharmaceutical News reports that the FDA has issued warnings about diet pills from Brazil marketed as dietary supplements, that contain Prozac and Librium.
- Conflict of Interest | Corrupt Practices | Current Controversies | Diagnostic Dragnet -- DSM | Pharma Corrupt Influence | Psych Drugs
Military Polypharmacy, PTSD: Deaths
"The problem of prescription overdose in the military has its parallel in civilian life. The tragic overdose victims in both spheres represent canaries in the coal mine–only the most obvious victims of what has become our national orgy of over using psychotropic drugs." Allen Frances MD
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
Public Furor Forces NYU to Pull Ransom Note Ad Campaign
Good news but continued vigilance required! A backlash by outraged parents and advocates for responsible evidence-based rhetoric about physical and mental health issues, forced Dr. Harold Koplewicz, founder and director of the NYU Child Study Center, to pull the irresponsible, fear mongering "ransom note" ad campaign in which threats and…
FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.